SCHEMBL6089976

SCHEMBL6089976

O=C(Nc1c(C(=O)O)n(Cc2cccc(Cl)c2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12)c1ccc(Cl)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGES O14684 1/20 0.44
PLA2G2A P14555 1/20 0.43
PPARG P37231 10/20 0.43
ABCB1 P08183 3/20 0.43
SLC2A1 P11166 1/20 0.43
HSPH1 Q92598 1/20 0.41
PTGER4 P35408 1/20 0.41
MEN1 O00255 1/20 0.41
CYP3A4 P08684 1/20 0.41
MAPT P10636 1/20 0.41
ALOX15 P16050 1/20 0.41
TSHR P16473 1/20 0.41
ALOX12 P18054 1/20 0.41
RECQL P46063 1/20 0.41
BLM P54132 1/20 0.41
KMT2A Q03164 1/20 0.41
HSD17B10 Q99714 1/20 0.41
PTGES2 Q9H7Z7 1/20 0.41
PPARD Q03181 2/20 0.41
NR1H4 Q96RI1 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6091451 0.93 SLC2A1 (0.44) PTGESPLA2G2APPARGABCB1SLC2A1
SCHEMBL6090836 0.93 PPARG (0.47) PTGESPPARGABCB1PTGER4MEN1
SCHEMBL6091652 0.88 SERPINE1 (0.54) PTGESPLA2G2APPARGPTGES2
SCHEMBL6091492 0.86 THRB (0.43) PTGESPLA2G2APPARGMEN1MAPT
SCHEMBL6091368 0.86 GRIN1 (0.43) PTGESPLA2G2APPARGSLC2A1HSPH1
SCHEMBL5749488 0.85 PTGER4 (0.46) PTGESPLA2G2APPARGABCB1SLC2A1
SCHEMBL6093040 0.84 SERPINE1 (0.45) PTGESPLA2G2APPARGABCB1SLC2A1
SCHEMBL6092421 0.83 PTGES (0.57) PTGESPPARGABCB1SLC2A1PTGER4
SCHEMBL6091169 0.83 ALDH1A1 (0.46) PLA2G2APPARGSLC2A1CYP3A4MAPT
SCHEMBL5748986 0.82 PTGER4 (0.42) PTGESPLA2G2APPARGABCB1SLC2A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060160879-A1 Indoles useful in the treatment of inflammation BIOLIPOX AB (SE) 2006-07-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060160879-A1 Indoles useful in the treatment of inflammation IDO1, PTGS1, IDO2 PTGES 4/4885PLA2G2A 982/4885PPARG 481/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.